胰腺癌的临床试验
总计54928个结果
-
Brown UniversityRhode Island Hospital; Memorial Hospital of Rhode Island; Lifespan完全的
-
Brown UniversityGlaxoSmithKline完全的
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, Beijing完全的
-
PD Dr. med. Volker HeinemannUniversity of Cologne; Technical University of Munich未知
-
Gruppo Oncologico Italiano di Ricerca Clinica完全的
-
Chinese PLA General Hospital未知
-
Tianjin Medical University Cancer Institute and...未知
-
Centre hospitalier de l'Université de Montréal...Centre de Recherche du Centre Hospitalier de l'Université de Montréal完全的
-
Columbia UniversitySanofi完全的
-
Tragara Pharmaceuticals, Inc.完全的
-
CONKO-StudiengruppeEli Lilly and Company完全的
-
General Oncology, Inc.Myriad Genetics, Inc.招聘中胰腺癌 | 胰腺导管腺癌 | 胰腺癌 IV 期 | 乳腺癌第四期 | BRCA1突变 | BRCA2突变 | 胰腺腺泡细胞癌 | 转移性胰腺癌 | 乳腺癌转移 | HER2 阴性乳腺癌 | 转移性胰腺导管腺癌 | HER2 阴性乳腺癌 | 胰腺癌转移 | 乳腺癌 | PALB2基因突变美国
-
M.D. Anderson Cancer Center主动,不招人胰腺导管腺癌 | IV 期胰腺癌 AJCC v8 | 转移性胰腺癌 | KRAS NP_004976.2:p.G12D美国
-
National Cancer Institute (NCI)主动,不招人III 期胰腺癌 AJCC v8 | IV 期胰腺癌 AJCC v8 | 转移性胰腺癌 | 局部晚期胰腺癌美国, 以色列, 加拿大
-
National Cancer Institute (NCI)完全的不可切除的胰腺癌 | 转移性胰腺癌 | III 期胰腺癌 AJCC v6 和 v7 | IV 期胰腺癌 AJCC v6 和 v7美国
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)撤销
-
Zhejiang Provincial People's HospitalHangzhou Neoantigen Therapeutics Co., Ltd.招聘中
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Odense University Hospital; Medical University of Vienna; Maastricht University Medical Center; UMC... 和其他合作者招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Genzyme, a Sanofi Company; American Association for Cancer Research完全的
-
University Hospital, Basel, SwitzerlandSt. Clara Research Ltd.终止
-
Oslo University HospitalUniversity of Oslo; University Hospital of North Norway; University of Bergen; Helse Stavanger HF; Haukeland University Hospital 和其他合作者邀请报名